2013•Zhongguo yaofangRequires access

Determination of the Blood Concentration of Mycophenolate Mofetil in Lupus Nephritis Patients by HPLC

Xu Yi

Open publisher page 0 citations

Abstract

OBJECTIVE:To determine the blood concentration of mycophenolate mofetil(MMF)in the lupus nephritis(LN)patients. METHODS:HPLC was used for determining MMF metabolite mycophenolic acid(MPA)after blood sample of LN patients trated. SGE Protecol C18 column was used with mobile phase consisted of methanol-acetonitrile0.01% phosphoric acid(23 ∶ 37 ∶ 40,V/V/V)at the flow rate of 1.0 ml/min. The detection wavelength was set at 216 nm,and injection volume was 20 μl. The column temperature was 30 ℃. RESULTS:The linear range of MPA was 0.125-10 mg/L(r=0.999 9)with method recovery of 98.67%-104.31% and extraction recovery of 83.43% -97.54% . The extraction recovery of internal standard(nimesulide)was 79.35% . RSDs of inter-day and intra-day were 2.6%-7.7% and 2.3%-8.5%,respectively. CONCLUSIONS:The method is simple and accurate,and can be used for blood concentrations monitoring of MPA in LN patients after taking MMF.

About this research paper

What this paper is about

OBJECTIVE:To determine the blood concentration of mycophenolate mofetil(MMF)in the lupus nephritis(LN)patients. METHODS:HPLC was used for determining MMF metabolite mycophenolic acid(MPA)after blood sample of LN patients trated. SGE Protecol C18 column was used with mobile phase consisted of methanol-acetonitrile0.01% phosphoric acid(23 ∶ 37 ∶ 40,V/V/V)at the flow rate of 1.0 ml/min. The detection wavelength was set at 216 nm,and injection volume was 20 μl. The column temperature was 30 ℃. RESULTS:The linear range of MPA was 0.125-10 mg/L(r=0.999 9)with method recovery of 98.67%-104.31% and extraction recovery of 83.43% -97.54% . The extraction recovery of internal standard(nimesulide)was 79.35% . RSDs of inter-day and intra-day were 2.6%-7.7% and 2.3%-8.5%,respectively. CONCLUSIONS:The method is simple and accurate,and can be used for blood concentrations monitoring of MPA in LN patients after taking MMF.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To determine the blood concentration of mycophenolate mofetil(MMF)in the lupus nephritis(LN)patients. METHODS:HPLC was used for determining MMF metabolite mycophenolic acid(MPA)after blood sample of LN patients trated. SGE Protecol C18 column was used with mobile phase consisted of methanol-acetonitrile0.01% phosphoric acid(23 ∶ 37 ∶ 40,V/V/V)at the flow rate of 1.0 ml/min. The detection wavelength was set at 216 nm,and injection volume was 20 μl. The column temperature was 30 ℃. RESULTS:The linear range of MPA was 0.125-10 mg/L(r=0.999 9)with method recovery of 98.67%-104.31% and extraction recovery of 83.43% -97.54% . The extraction recovery of internal standard(nimesulide)was 79.35% . RSDs of inter-day and intra-day were 2.6%-7.7% and 2.3%-8.5%,respectively. CONCLUSIONS:The method is simple and accurate,and can be used for blood concentrations monitoring of MPA in LN patients after taking MMF.

Key concepts: Mycophenolate, Mycophenolic acid, Chromatography, Phosphoric acid, Lupus nephritis, Chemistry, High-performance liquid chromatography, Nimesulide

Related papers

Back to paper searchBrowse research topicsOriginal source
Determination of the Blood Concentration of Mycophenolate Mofetil in Lupus Nephritis Patients by HPLC — Research Paper | ScholarLens